US Stock MarketDetailed Quotes

Processa Pharmaceuticals (PCSA)

Watchlist
  • 3.540
  • -0.170-4.58%
Close Jan 16 16:00 ET
  • 3.630
  • +0.090+2.54%
Post 19:07 ET
8.02MMarket Cap-0.12P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Processa Pharmaceuticals (PCSA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1.87%3.49M
28.19%3.95M
1.33%2.85M
5.19%12.05M
10.74%2.73M
58.00%3.42M
13.54%3.08M
-31.57%2.81M
-43.44%11.46M
-57.42%2.47M
Selling and administrative expenses
60.66%1.83M
11.24%1.5M
-0.95%1.26M
-15.47%4.78M
-11.01%1.02M
11.96%1.14M
31.69%1.35M
-48.73%1.27M
-35.44%5.66M
-56.25%1.15M
-General and administrative expense
60.66%1.83M
11.24%1.5M
-0.95%1.26M
-15.47%4.78M
-11.01%1.02M
11.96%1.14M
31.69%1.35M
-48.73%1.27M
-35.44%5.66M
-56.25%1.15M
Research and development costs
-27.36%1.66M
41.43%2.45M
3.21%1.59M
25.34%7.27M
29.66%1.71M
98.61%2.29M
2.50%1.73M
-5.43%1.54M
-49.54%5.8M
-58.39%1.32M
Operating profit
-1.87%-3.49M
-28.19%-3.95M
-1.33%-2.85M
-5.19%-12.05M
-10.74%-2.73M
-58.00%-3.42M
-13.54%-3.08M
31.57%-2.81M
43.44%-11.46M
57.42%-2.47M
Net non-operating interest income expense
30.00%52K
-84.88%12.59K
-40.07%201.09K
-90.56%6.09K
-53.30%40K
-0.29%83.22K
231.56%335.54K
16.19%64.52K
Non-operating interest income
30.00%52K
----
-84.88%12.59K
-40.07%201.09K
-90.56%6.09K
-53.30%40K
----
-0.29%83.22K
231.56%335.54K
16.19%64.52K
Other net income (expense)
80.00%270
-76.48%16.87K
150
-29.64%71.7K
Other non- operating income (expenses)
80.00%270
-76.48%16.87K
----
----
----
--150
-29.64%71.7K
----
----
----
Income before tax
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
Income tax
0
0
Net income
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
Net income continuous Operations
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
Minority interest income
Net income attributable to the parent company
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
Basic earnings per share
93.20%-1.75
75.25%-6.25
72.97%-7.5
54.36%-96.75
55.69%-18.5
33.12%-25.75
47.94%-25.25
68.56%-27.75
75.10%-212
89.60%-41.75
Diluted earnings per share
93.20%-1.75
75.25%-6.25
72.97%-7.5
54.36%-96.75
55.69%-18.5
33.12%-25.75
47.94%-25.25
68.56%-27.75
75.10%-212
89.60%-41.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1.87%3.49M28.19%3.95M1.33%2.85M5.19%12.05M10.74%2.73M58.00%3.42M13.54%3.08M-31.57%2.81M-43.44%11.46M-57.42%2.47M
Selling and administrative expenses 60.66%1.83M11.24%1.5M-0.95%1.26M-15.47%4.78M-11.01%1.02M11.96%1.14M31.69%1.35M-48.73%1.27M-35.44%5.66M-56.25%1.15M
-General and administrative expense 60.66%1.83M11.24%1.5M-0.95%1.26M-15.47%4.78M-11.01%1.02M11.96%1.14M31.69%1.35M-48.73%1.27M-35.44%5.66M-56.25%1.15M
Research and development costs -27.36%1.66M41.43%2.45M3.21%1.59M25.34%7.27M29.66%1.71M98.61%2.29M2.50%1.73M-5.43%1.54M-49.54%5.8M-58.39%1.32M
Operating profit -1.87%-3.49M-28.19%-3.95M-1.33%-2.85M-5.19%-12.05M-10.74%-2.73M-58.00%-3.42M-13.54%-3.08M31.57%-2.81M43.44%-11.46M57.42%-2.47M
Net non-operating interest income expense 30.00%52K-84.88%12.59K-40.07%201.09K-90.56%6.09K-53.30%40K-0.29%83.22K231.56%335.54K16.19%64.52K
Non-operating interest income 30.00%52K-----84.88%12.59K-40.07%201.09K-90.56%6.09K-53.30%40K-----0.29%83.22K231.56%335.54K16.19%64.52K
Other net income (expense) 80.00%270-76.48%16.87K150-29.64%71.7K
Other non- operating income (expenses) 80.00%270-76.48%16.87K--------------150-29.64%71.7K------------
Income before tax -1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M
Income tax 00
Net income -1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M
Net income continuous Operations -1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M
Minority interest income
Net income attributable to the parent company -1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M
Basic earnings per share 93.20%-1.7575.25%-6.2572.97%-7.554.36%-96.7555.69%-18.533.12%-25.7547.94%-25.2568.56%-27.7575.10%-21289.60%-41.75
Diluted earnings per share 93.20%-1.7575.25%-6.2572.97%-7.554.36%-96.7555.69%-18.533.12%-25.7547.94%-25.2568.56%-27.7575.10%-21289.60%-41.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -